The role of myocardial scintigraphy in the assessment of cardiovascular risk in patients with end-stage chronic kidney disease on the waiting list for renal transplantation.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The usefulness of stress myocardial perfusion scintigraphy for cardiovascular (CV)
risk stratification in chronic kidney disease remains controversial. We tested the
hypothesis that different clinical risk profiles influence the test.